Clinical Trial Update: Delayed Versus Immediate Use Of Zoledronic Acid For Postmenopausal Patients With Early Breast Cancer Who Are Using Adjuvant Letrozole [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating delayed versus immediate use of zoledronic acid in postmenopausal early breast cancer patients on adjuvant letrozole.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Assiut University | Conditions: Use of Zoledronic Acid in Breast Cancer | Phase 3 | Status: UNKNOWN